Resistance to Immunomodulatory Drugs in Multiple Myeloma: The Cereblon Pathway and Beyond

The authors provide a comprehensive overview of the existing work on immunomodulatory drugs (IMiD) resistance in multiple myeloma (MM), focusing specifically on the emerging evidence of CRBN pathway-independent mechanisms.